Compile Data Set for Download or QSAR
maximum 50k data
Found 2318 of ic50 data for polymerid = 2142,3429,3430,8334
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM198005(US9221790, 15)
Affinity DataIC50:  0.00200nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197995(US9221790, 5)
Affinity DataIC50:  0.00500nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197993(US9221790, 3)
Affinity DataIC50:  0.0390nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328390(3-(difluoromethyl)-6-fluoro-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.0660nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197997(US9221790, 7)
Affinity DataIC50:  0.0670nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328384(3-(difluoromethyl)-5-fluoro-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.0740nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM198000(US9221790, 10)
Affinity DataIC50:  0.0760nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328391(6-chloro-3-(difluoromethyl)-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  0.0850nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328397(6-chloro-3-(difluoromethyl)-1-((3-(4-isopropylpipe...)
Affinity DataIC50:  0.0900nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328394(3-(difluoromethyl)-6-bromo-1-((4-methoxy-3-(4-meth...)
Affinity DataIC50:  0.0900nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328396(6-chloro-1-((3-(4-cyclopropylpiperazin-1-yl)-4-met...)
Affinity DataIC50:  0.0920nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328392(3-(difluoromethyl)-6-chloro-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.100nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197996(US9221790, 6)
Affinity DataIC50:  0.103nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50587586(CHEMBL5078731)
Affinity DataIC50:  0.120nMAssay Description:Modulation of human 5HT2C expressed in HEK293T cells co-transfected with Galphaq-RLuc8, Ggamma1-GFP2 and Gbeta1 assessed as dissociation of Galphaq f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328395(6-chloro-3-(difluoromethyl)-1-((3-(4-ethylpiperazi...)
Affinity DataIC50:  0.130nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM198003(US9221790, 13)
Affinity DataIC50:  0.134nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328400(3-(difluoromethyl)-1-((4-methoxy-3-(4-methylpipera...)
Affinity DataIC50:  0.140nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328380(6-chloro-1-((4-methoxy-3-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  0.140nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197992(US9221790, 2)
Affinity DataIC50:  0.164nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM50156203(CHEMBL3781299)
Affinity DataIC50:  0.170nMAssay Description:Displacement of [3H]LSD from human 5-HT6 receptor expressed in CHO cell membranes after 120 mins by liquid scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328381(6-bromo-1-((4-methoxy-3-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50:  0.170nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197998(US9221790, 8)
Affinity DataIC50:  0.182nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328388(3-(difluoromethyl)-5-bromo-1-((4-methoxy-3-(4-meth...)
Affinity DataIC50:  0.200nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50249132((4-((1H-imidazol-2-yl)methyl)piperidin-1-yl)(4'-fl...)
Affinity DataIC50:  0.200nMAssay Description:Antagonist activity at 5-HT2B receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of serotonin-induced intracellular Ca2+ flux ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328379(6-chloro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  0.210nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM29525(3H-GR113808 | CHEMBL518682 | GR 113808 | [3H] GR 1...)
Affinity DataIC50:  0.210nMAssay Description:Antagonist activity at human 5HT4ER expressed in CHO cells assessed as reduction in cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328386(5-chloro-3-(difluoromethyl)-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.220nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197991(US9221790, 1)
Affinity DataIC50:  0.226nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM111790(US8618114, 1.2.22(5).HCl)
Affinity DataIC50:  0.227nMAssay Description:Screening of the disclosed compounds for their potential ability to interact with serotonin 5-HT6 receptors was carried out by method of radioligand ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197994(US9221790, 4)
Affinity DataIC50:  0.229nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50587589(CHEMBL5081637)
Affinity DataIC50:  0.245nMAssay Description:Modulation of human 5HT2B expressed in HEK293T cells co-transfected with Galphaq-RLuc8, Ggamma1-GFP2 and Gbeta1 assessed as dissociation of Galphaq f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328401(3-(difluoromethyl)-1-((3-(4-ethylpiperazin-1-yl)-4...)
Affinity DataIC50:  0.25nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328389(3-(difluoromethyl)-6-fluoro-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  0.260nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM197999(US9221790, 9)
Affinity DataIC50:  0.267nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM50156201(CHEMBL3781323)
Affinity DataIC50:  0.280nMAssay Description:Displacement of [3H]LSD from human 5-HT6 receptor expressed in CHO cell membranes after 120 mins by liquid scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM111771(US8618114, 1.2.11(1))
Affinity DataIC50:  0.293nMAssay Description:Screening of the disclosed compounds for their potential ability to interact with serotonin 5-HT6 receptors was carried out by method of radioligand ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50249483(1-(biphenyl-4-ylsulfonyl)-4-(1H-imidazol-2-yl)pipe...)
Affinity DataIC50:  0.300nMAssay Description:Antagonist activity at 5-HT2B receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of serotonin-induced intracellular Ca2+ flux ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM50156209(CHEMBL3780579)
Affinity DataIC50:  0.310nMAssay Description:Displacement of [3H]LSD from human 5-HT6 receptor expressed in CHO cell membranes after 120 mins by liquid scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328393(3-(difluoromethyl)-6-bromo-1-((4-methoxy-3-(pipera...)
Affinity DataIC50:  0.330nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Usona Institute

Curated by ChEMBL
LigandPNGBDBM85097(CAS_181632-25-7 | CHEMBL14563 | SB 242084)
Affinity DataIC50:  0.330nMAssay Description:Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM50417932(CHEMBL1668587 | US8618114, 1.2.4(1))
Affinity DataIC50:  0.340nMAssay Description:Screening of the disclosed compounds for their potential ability to interact with serotonin 5-HT6 receptors was carried out by method of radioligand ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM50005836(4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl...)
Affinity DataIC50:  0.362nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM198004(US9221790, 14)
Affinity DataIC50:  0.375nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50249464((4-((1H-imidazol-2-yl)methyl)piperidin-1-yl)(biphe...)
Affinity DataIC50:  0.400nMAssay Description:Antagonist activity at 5-HT2B receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of serotonin-induced intracellular Ca2+ flux ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328402(1-((3-(4-cyclopropylpiperazin-1-yl)-4-methoxypheny...)
Affinity DataIC50:  0.400nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM50158027(4-[5-Methoxy-3-(1,2,3,6-tetrahydro-pyridin-4-yl)-i...)
Affinity DataIC50:  0.400nMAssay Description:Inhibitory concentration against 5-HT stimulated cAMP production in HeLa cells stably transfected with human 5-HT6 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328399(3-(difluoromethyl)-1-((4-methoxy-3-(piperazin-1-yl...)
Affinity DataIC50:  0.400nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 4(Homo sapiens (Human))
Dong-A Pharm.

US Patent
LigandPNGBDBM198002(US9221790, 12)
Affinity DataIC50:  0.421nMAssay Description:The binding affinity of the compounds for a human 5-HT4 receptor was assayed according to the method as disclosed in the literature [Wyngaert et al.,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328366(4-fluoro-1-((4-methoxy-3-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  0.430nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328408(5-fluoro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  0.430nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 2318 total ) | Next | Last >>
Jump to: